ARCHIVES

DCT Board Approves New RFA For Aids Clinical Trials Groups

This article is from The Cancer Letter archive.

Vol. 20 No. 43 | November 11, 1994

Download PDF Visit The Full Archive

Related Articles

Rep. Wyden Questions NCI Motive For Choosing Not To Pursue RU 486

September 4, 1992

In Brief: Patterns Of care Study Leads “Part Tie” Radiotherapists To Drop Out, Sheline Says

July 22, 1977

NCI Advisors Approve $160-Million Network For Biomarker Discovery, Validation

March 13, 2009

ASCO Highlights Six Studies From Meeting To Showcase Advances In Cancer Care

May 30, 2008

In Brief: Pasche Named Director of Wake Forest Cancer Center

March 7, 2014

FDA Names Director Of New Center For Tobacco Products

September 11, 2009